TARRYTOWN, N.Y., Feb. 2, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast a management presentation at the following investor conference:


    --  Leerink Partners 5(th) Annual Global Healthcare Conference at 8:30 a.m.
        Eastern Time on Thursday, February 11, 2016

The session may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentation will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
 Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:



    Investor Relations               Corporate Communications

    Manisha Narasimhan, Ph.D.        Hala Mirza

    914.847.5126                     914.847.3422

    manisha.narasimhan@regeneron.com hala.mirza@regeneron.com
                                     ------------------------

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-2016-investor-conference-presentation-300213556.html

SOURCE Regeneron Pharmaceuticals, Inc.